Citations

Clear

184 citation(s) found for "Ferman, Tanis J".

Non-Amnestic Mild Cognitive Impairment Progresses to Dementia with Lewy Bodies (S24.002)
Pankratz, V. Shane , Graff‐Radford, Neill R. , Uitti, Ryan J. , Gerpen, Jay Van, Pedraza, Otto , Petersen, Ronald, Ferman, Tanis J. , Smith, Glenn E. , Kantarci, Kejal , Boeve, Bradley F. , Wszołek, Zbigniew K. , Gerpen, Jay A. van, Knopman, David S. , Dickson, Dennis W. , Petersen, Ronald

Mayo Clinic

Neurology | December 7, 2023 | Volume: 80 | Issue: 7_supplement | Pages: No page available

10.1212/wnl.80.7_supplement.s24.002 Get It

DaTscan Findings in Patients with Mild Cognitive Impairment, Alzheimer's Disease and Dementia with Lewy Bodies (P06.046)
Lowe, Val J. , Silber, Michael H. , Ivnik, Robert J., Petersen, Ronald, Boeve, Bradley F. , Kantarci, Kejal , Ferman, Tanis J. , Louis, Erik K. St. , Smith, Glenn E. , Knopman, David S. , Jack, Clifford R. , Petersen, Ronald

Mayo Clinic

Neurology | December 7, 2023 | Volume: 80 | Issue: 7_supplement | Pages: No page available

10.1212/wnl.80.7_supplement.p06.046 Get It

Clinicopathologic Variability of GRN A9D Mutation, Including Amyotrophic Lateral Sclerosis (P05.077)
Ashley, Cannon, Traynor, Sharleen , Rutherford, Nicola J., Broderick, Daniel F. , Graff‐Radford, Neill R. , Uitti, Ryan J. , Rademakers, Rosa , Fujioka, Shinsuke , Ferman, Tanis J. , Boylan, Khrista , Wszołek, Zbigniew K. , Dickson, Dennis W.

Mayo Clinic

Neurology | December 7, 2023 | Volume: 80 | Issue: 7_supplement | Pages: No page available

10.1212/wnl.80.7_supplement.p05.077 Get It

DaTscan Findings in Patients with Mild Cognitive Impairment, Alzheimer's Disease and Dementia with Lewy Bodies (IN3-1.008)
Lowe, Val J. , Silber, Michael H. , Ivnik, Robert J., Petersen, Ronald, Boeve, Bradley F. , Kantarci, Kejal , Ferman, Tanis J. , Louis, Erik K. St. , Smith, Glenn E. , Knopman, David S. , Jack, Clifford R. , Petersen, Ronald

Mayo Clinic

Neurology | December 7, 2023 | Volume: 80 | Issue: 7_supplement | Pages: No page available

10.1212/wnl.80.7_supplement.in3-1.008 Get It

Retrospective Evaluation of Neuropathologic Proxies of the Minimal Atrophy Subtype Compared With Corticolimbic Alzheimer Disease Subtypes
Boon, Baayla D.C. , Labuzan, Sydney A. , Peng, Zhongwei , Matchett, Billie J. , Hinkle, Kelly M., Lachner, Christian , Ross, Owen A. , Ertekin‐Taner, Nilüfer , Carter, Rickey E. , Ferman, Tanis J. , Duara, Ranjan , Graff‐Radford, Neill R. , Kouri, Naomi , Duara, Ranjan , Dickson, Dennis W , Murray, Melissa E , Ross, Owen A , Carter, Rickey E , Ferman, Tanis J , Dickson, Dennis W. , Murray, Melissa E.

Mayo Clinic

Neurology | August 14, 2023 | Volume: 101 | Issue: 14 | Pages: No page available

10.1212/wnl.0000000000207685 | PMID 37580158 Get It

The association of amyloid‐beta, tau, and cerebrovascular biomarkers with neurodegeneration in dementia with Lewy bodies
Przybelski, Scott A. , Lesnick, Timothy G. , Graff‐Radford, Jonathan , Fields, Julie A. , Savica, Rodolfo , Graff‐Radford, Neill R. , Lowe, Val J. , Petersen, Ronald C. , Ferreira, Daniel , Schwarz, Christopher G. , Diaz‐Galvan, Patricia , Senjem, Matthew L. , Ferman, Tanis J. , Jack, Clifford R. , Westman, Eric , Boeve, Bradley F. , Kantarci, Kejal

Mayo Clinic

Alzheimer's & Dementia | June 16, 2023 | Volume: 19 | Issue: S3 | Pages: No page available

10.1002/alz.067971 Get It

AbstractBackgroundDementia with Lewy bodies (DLB) is the second most common neurodegenerative dementia, after Alzheimer’s disease (AD). While alpha‐synuclein pathology is the hallmark of DLB, AD and cerebrovascular pathologies are common in DLB patients. However, the contribution of these pathologies towards neurodegeneration in DLB is largely unknown. We investigated associations of amyloid‐beta, tau, and cerebrovascular biomarkers with regional gray matter (GM) volume in DLB patients and cognitively unimpaired (CU) controls.MethodWe included 30 DLB patients (69.3±10.2 years old, 87% men) and 100 CU individuals balanced on age and sex (Table 1). We used 11C‐Pittsburgh Compound‐B (PiB) and 18F‐Flortaucipir positron emission tomography (PET) to assess amyloid‐beta and tau in‐vivo. We used structural MRI to assess white matter hyperintensity (WMH) volume, a marker of cerebrovascular lesion load, and regional GM volume (a marker of neurodegeneration). We used correlations and ANCOVA in the whole dataset and structural equation modelling in the DLB patients to investigate associations of WMH volume and regional amyloid‐beta and tau PET standardized uptake value ratios (SUVRs) with regional GM volume.ResultDLB patients showed lower GM volume across all cortical and subcortical regions except for cuneus, putamen, and pallidum (Fig.1). Greater WMH volume was associated with lower volume in the medial and orbital frontal cortices, insula, fusiform cortex, and thalamus in DLB patients (Fig.2). Greater PiB SUVR was associated with lower volume in the inferior temporal cortex, while Flortaucipir SUVR did not correlate with GM volume (Fig.2). Structural equation modelling showed that higher age and positivity for the APOE e4 genotype were significant predictors of greater WMH, and WMH in turn was a significant predictor of GM volume in medial and orbital frontal cortices, insula, and inferior temporal cortex (Fig.3). In contrast, we observed two distinct paths for the fusiform cortex, with age having an effect through PiB and Flortaucipir SUVRs on the one path, and through WMH on the other path (Fig.3).ConclusionDLB patients have widespread cortical atrophy, most of which likely is influenced by alpha‐synuclein pathology. Although amyloid‐beta, tau, and cerebrovascular pathologies often coexist in DLB, their contributions to neurodegeneration seem to be region specific.